Filing Details
- Accession Number:
- 0001209191-21-067237
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-01 10:28:34
- Reporting Period:
- 2021-11-30
- Accepted Time:
- 2021-12-01 10:28:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1207430 | H Jose Bedoya | 604 10Th Street Boulder CO 80302 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-30 | 5,576 | $21.31 | 28,393 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-30 | 5,576 | $44.00 | 22,817 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-11-30 | 5,576 | $0.00 | 5,576 | $21.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-12-03 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average price of 5,576 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 30, 2021 with sale prices ranging from $43.50 to $44.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The amount beneficially owned includes 10,610 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
- Fully vested.
Billionaire Hedge Funds
